Clinical Trials

Neoplasms

NCT06658405 2026-03-18

HPV2

85 enrolled

Neoplasms

NCT07202507 2026-03-18

SNOOZE

20 enrolled

Phase 2/3 Not yet recruiting

Neoplasms

NCT07476443 2026-03-17

VitC-CoQ10

75 enrolled

Neoplasms

NCT00420563 2026-03-16

PAL-ANGI

Phase 2 Completed

88 enrolled

Neoplasms

NCT01198119 2026-03-16

NBI-CAB

Phase 2 Terminated

23 enrolled

Head & Neck

Mouth Neoplasms, Neoplasms

NCT01721343 2026-03-16

Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer

516 enrolled

Neoplasms, Pain

NCT02439047 2026-03-16

MESO-PATCH

Phase NA Terminated

6 enrolled

Neoplasms

NCT05468359 2026-03-16

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

64 enrolled

Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular, Neoplasms

NCT05887882 2026-03-16

PNOC028

Phase 1 Recruiting

24 enrolled

Neoplasms

NCT06072833 2026-03-16

Characterizing and Addressing Financial Toxicity in AYAs With Cancer

26 enrolled 8 charts

Phase 1 Active not recruiting

Neoplasms

NCT07474168 2026-03-16

T Cell Receptor Gene-Engineered and Dominant Negative TGF-β Receptor T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor

9 enrolled

Neoplasms

NCT00580515 2026-03-13

Trial of Family Focused Grief Therapy in Palliative Care and Bereavement

700 enrolled

Neoplasms

NCT01042379 2026-03-13

I-SPY

DermatologicGastrointestinalSarcoma

5,000 enrolled

BreastSarcoma

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

NCT01046487 2026-03-13

PALANGI3

Phase 1 Completed

26 enrolled

Uveal Melanoma, Chordoma, Carcinoma, Adenoid Cystic, Neoplasms, Desmoid Tumors, Dermatofibrosarcoma, Gastrointestinal Stromal Tumors

NCT01247779 2026-03-13

ROBO-GYN

386 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT01596816 2026-03-13

CKNO-PRO

Phase 2 Completed

76 enrolled

GastrointestinalGenitourinary

Neoplasms, Prostatic Neoplasms

NCT01641484 2026-03-13

ANOXICOL

Phase NA Terminated

9 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasms

NCT03652298 2026-03-13

NeuroPrevPTSD

Phase 2 Terminated

19 enrolled

Urinary Bladder Neoplasms, Kidney Neoplasms, Neoplasms, Prostatic Neoplasms, Stress Disorders, Post-Traumatic, Colorectal Neoplasms

NCT07454031 2026-03-13

Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma

Phase 1 Not yet recruiting

22 enrolled

Neoplasm Metastasis, Neoplasms

NCT07469683 2026-03-13

An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma

78 enrolled

Carcinoma, Renal Cell, Neoplasms

NCT07469761 2026-03-13

MISTRAL

Phase EARLY_PHASE1 Completed

120 enrolled

Frailty, Neoplasms

NCT01804712 2026-03-12

Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy

8 enrolled 12 charts

Neoplasms, Prostatic Neoplasms

NCT04803604 2026-03-12

CASCADE

256 enrolled

Neoplasms

NCT06053086 2026-03-12

SAHARA-04

500 enrolled

Breast

Breast Neoplasms, Neoplasms

NCT06445140 2026-03-12

MONAGE

55 enrolled

Neoplasms

NCT06768918 2026-03-12

AMBeR eRehab

300 enrolled

Motor Activity, Neoplasms

NCT06824441 2026-03-12

Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer

83 enrolled

Adolescent Behavior, Neoplasms

NCT06868524 2026-03-12

LEAP

100 enrolled

Motor Activity, Neoplasms

NCT06959810 2026-03-12

OEUVRE

55 enrolled

Neoplasms

NCT07050771 2026-03-12

Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery

148 enrolled

GenitourinaryGynecologic

Urinary Bladder Neoplasms, Kidney Neoplasms, Neoplasms, Ovarian Neoplasms

NCT07052110 2026-03-12

DST in Reducing Depressive Symptoms, Enhancing Self-esteem, and Promoting Quality of Life Among CCSs

248 enrolled

Depression, Neoplasms

NCT07150117 2026-03-12

CYCLE-CIPN

30 enrolled

Motor Activity, Neoplasms, Peripheral Nervous System Diseases

NCT07296887 2026-03-12

CARE Tool Study Aim 3

GastrointestinalGenitourinaryThoracic

430 enrolled

Financial Stress, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT07466862 2026-03-12

Personalized Cooking and Nutrition Guidance and Physical Activities Program to Reduce Muscle Loss in Advanced Cancer

200 enrolled

Anosmia, Food Preferences, Neoplasms, Sarcopenia

NCT03694015 2026-03-11

SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases

Phase NA Terminated

160 enrolled

Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Pathologic Processes

NCT05763797 2026-03-11

Developing a Culturally Relevant Supportive Care Program for Black Patients Dealing With Advanced Cancer

170 enrolled

Neoplasms

NCT06864260 2026-03-11

PREEMpT

300 enrolled

Neoplasms

NCT07463547 2026-03-11

WISE

20 enrolled

Neoplasms

NCT07463833 2026-03-11

Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology

207 enrolled

Neoplasms, Prostatic Neoplasms

NCT07464132 2026-03-11

Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

30 enrolled

Cardiomyopathy, Hypertrophic, Cardiovascular Diseases, Neoplasms, Pulmonary Fibrosis

NCT02780128 2026-03-10

NEPENTHE

Phase 1 Terminated

66 enrolled

CNS

Neoplasms, Neuroblastoma

NCT04333706 2026-03-10

EMPOWER

65 enrolled

Phase NA Enrolling by invitation

Neoplasm Metastasis, Neoplasms

NCT06645093 2026-03-10

FasteStudien

40 enrolled

Lymphoid

Intermittent Fasting, Fasting, Lymphoma, Neoplasms

NCT04723810 2026-03-09

TumorGlow Intraoperative Molecular Imaging (IMI)

500 enrolled

Phase 1 Active not recruiting

Neoplasms

NCT05707910 2026-03-09

Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors

6 enrolled

Neoplasms

NCT06240390 2026-03-09

Effectiveness of Percutaneous Neuromodulation vs Pharmacological Treatment in Cancer Patients With Anterior Knee Pain

Phase NA Withdrawn

Cancer Pain, Neoplasms, Pain

NCT06549153 2026-03-09

ACT-Together (Acting on Cancer Testing-Together)

30 enrolled

Neoplasms

NCT06747910 2026-03-09

Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma